This ICR collects information from
manufacturers of infusion pumps who intend to submit a safety
assurance case (assurance case) with their premarket notification
(510(k)) submission. Based on the information provided in the
premarket notification (510(k)) submission, FDA determines whether
a new device provides reasonable assurance of the safety and
effectiveness of the device through substantial equivalence to a
legally marketed device and whether the device can, therefore, be
allowed to enter the U.S. market. However, FDA also believes an
assurance case can be used to support claims that a device is safe
for use. An assurance case is a systematic method of documenting a
claim through a series of structured arguments, supported by a body
of evidence that provides a compelling, comprehensible and valid
case that the claim is true. Manufacturers submitting a 510(k) for
modifications to a legally marketed infusion pump for which no
assurance case exists, should develop and submit an assurance case
for their infusion pump.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.